Results 221 to 230 of about 96,147 (311)

Effects of phased joint intervention on IL-35 and IL-17 expression levels in patients with portal hypertension

, 2014
Yugang Wang, Jinbin Dong, Wenying Meng, Jiali Ma, Na Wang, Jue Wei, Min Shi   +6 more
openalex   +2 more sources

Comparing the Molecular Pharmacological Properties of Existing β‐Blockers to Determine the Theoretically Most “Ideal” Anti‐Cancer β‐Blocker

Pharmacology Research &Perspectives, Volume 14, Issue 1, February 2026.
ABSTRACT There is increasing evidence, from cellular, animal and human epidemiological studies, linking β‐blockers with reductions in cancer growth and metastasis. Propranolol is the most investigated β‐blocker for cancer; although as many different off‐patent β‐blockers exist, there is little commercial incentive to drive comparative clinical trials ...
Jillian G. Baker
wiley   +1 more source

Risk factors and prediction model development for pancreatic fistula following splenectomy in Wilson's disease patients with portal hypertension. [PDF]

BMC Gastroenterol
Zheng Z, Shen Y, Min HC, Peng H, Huang L, Zhang WZ, Feng H, Yu QS.   +7 more
europepmc   +1 more source

Model‐Based Meta‐Analysis of the Relationship Between Pioglitazone and Histological Outcomes in Metabolic Dysfunction‐Associated Steatohepatitis Patients

CPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 2, February 2026.
ABSTRACT Given the high prevalence of the population who have metabolic dysfunction‐associated steatohepatitis (MASH), interest is growing in MASH‐targeted treatments. However, currently, there has been only one regulatory approved drug for MASH (Rezdiffra).
Quyen Thi Tran, Tham Thi Bui, Lien Thi Ngo, Bo Ram Yang, In‐Hwan Baek, Van Hung Nguyen, Kyung Ae Lee, Hwi‐yeol Yun, Jung‐woo Chae, Soyoung Lee, Jae Hyun Kim, Woojin Jung   +11 more
wiley   +1 more source

Application of artificial intelligence in portal hypertension and esophagogastric varices. [PDF]

World J Gastroenterol
Wang QC, Jiao J, Zhang CQ.
europepmc   +1 more source

Alcohol Use After TIPS Implantation Significantly Increases the Risk of ACLF and Liver‐Related Death

United European Gastroenterology Journal, Volume 14, Issue 1, February 2026.
ABSTRACT Background Complications related to portal hypertension (PH) in patients with alcohol‐related liver disease (ALD) can be controlled by transjugular intrahepatic portosystemic shunt (TIPS) placement; however, the impact of ongoing alcohol use (AU) after TIPS remains scarcely investigated.
Caroline Schwarz, Andrea Kornfehl, Reema Abid, Theresa Müllner‐Bucsics, Julia Kappel, Michael Schwarz, Benedikt S. Hofer, Nina Dominik, Georg Kramer, Benedikt Simbrunner, Mathias Jachs, Lukas Reider, Michael Trauner, Mattias Mandorfer, Thomas Reiberger, Lukas Hartl   +15 more
wiley   +1 more source

Never change a winning team-liver stiffness measurement and platelet count as key surrogates for clinically significant portal hypertension. [PDF]

Hepatobiliary Surg Nutr
Semmler G, Jachs M, Mandorfer M.
europepmc   +1 more source

Nutritional approach in a growing Jack Russell terrier with gall bladder agenesis

Veterinary Record Case Reports, Volume 14, Issue 1, February 2026.
Abstract An asymptomatic male Jack Russell terrier diagnosed at the age of 18 weeks with congenital gall bladder agenesis, confirmed by computed tomography scan, after finding abnormally high values for liver enzymes in a routine blood count. Treatment with liver‐protective agents S‐adenosylmethionine and ursodeoxycholic acid was initiated. At 6 months
Tamara Seghers, Matthias Dennler, Brigitta Wichert, Annette Liesegang   +3 more
wiley   +1 more source

Chronic portal hypertension following inotuzumab ozogamicin in a low-risk patient: a case of overriding baseline risk and long-term management. [PDF]

Ann Hematol
Wu J, Cao J, Gao L, Yang M, Shao J, Zhang Y, Xu X, Cai Y, Wei Y, Song X, Wan L.   +10 more
europepmc   +1 more source

Free Fetal Haemoglobin in Severe Early‐Onset Fetal Growth Restriction: A Prospective Multi‐Centre Study

BJOG: An International Journal of Obstetrics &Gynaecology, Volume 133, Issue 3, Page 401-411, February 2026.
ABSTRACT Objective To assess fetal circulating free fetal haemoglobin (fHbF) levels and heme defences, correlated to fetal circulatory biometry and fetal sex in severe early‐onset fetal growth restriction (FGR). Design, Setting and Population A prospective study severe early‐onset fetal growth restriction pregnancies with close clinical management ...
Adam Brook, Georgia Baynes, Jonathan Scargill, Angelos Evangelinos, Charlotte Brennan‐Richardson, Freya Dow, Yuval Ginsberg, Tal Weissbach, Jana Brodszki, Eva Hansson, Anke Diemert, Kurt Hecher, Katarzyna Maksym, Neil Marlow, Rebecca N. Spencer, Anna L. David, Stefan R. Hansson, Paul Brownbill   +17 more
wiley   +1 more source